About MetLife

• Founded: 1868

• Headquarters: New York City, United States

• AUM: $800bn in total assets (as of 2024)

• Strategy: Institutional insurance and asset management, alternatives allocation

• Track record: Long-term LP in private markets; prior secondaries activity includes $1.5bn LP stake sale in 2019

MetLife closed a $1.2bn managed account transaction with Lexington Partners, marking one of the larger single-LP deals in the secondaries market this year. The structure — a managed account rather than a direct LP stake sale — suggests MetLife is rotating exposure while maintaining some control over portfolio construction. No pricing details were disclosed.

The managed account format is worth attention. It allows MetLife to delegate selection and execution to Lexington while retaining governance levers that a clean LP stake sale would forfeit. That structure has become more common among insurers looking to rebalance alternatives exposure without fully exiting vintage diversification — Athene used a similar approach in 2022 with a $1bn mandate to Coller Capital. The question is whether MetLife is using this to derisk older vintages or to free up capacity for new commitments in a tighter deployment environment.

Lexington closed its tenth flagship fund at $22.6bn in 2023, making it the largest dedicated secondaries buyer globally. A $1.2bn mandate from a single institutional seller is significant but not unusual at that scale — it likely represents tail-end exposure across multiple fund vintages rather than a concentrated exit. If MetLife is moving pre-2018 vintages, pricing would reflect the current bid-ask tension: LP-led deals in Q1 2025 have traded at discounts averaging 8–12% to NAV, wider than the 4–6% range seen in late 2023. Whether this transaction cleared at similar levels will influence how other insurers approach liquidity over the next 12 months.

Source: Secondaries Investor